Is ex vivo adenovirus mediated gene transfer a therapeutic option for the treatment of corneal diseases?
Ritter, T
Ritter, T
Identifiers
http://hdl.handle.net/10379/9817
https://doi.org/10.13025/24534
https://doi.org/10.13025/24534
Repository DOI
Publication Date
2005-06-01
Type
Article
Downloads
Citation
Ritter, T (2005). Is ex vivo adenovirus mediated gene transfer a therapeutic option for the treatment of corneal diseases?. British Journal of Ophthalmology 89 (6), 648-649
Abstract
Improvements in vectors, promoters, and transgenes have to be accomplished before gene therapy could be considered as an option in cornea gene therapy.
Funder
Publisher
BMJ
Publisher DOI
Rights
Attribution-NonCommercial-NoDerivs 3.0 Ireland